Clonazepam tablets recalled for incorrect carton labeling
Endo USA is recalling approximately 9,816 cartons of Clonazepam 2 mg tablets due to incorrect strength labeling on the carton exterior. The blister strips inside contain the correct formulation.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification mandates minimum severity of Severe. Although the actual product inside contains the correct formulation, incorrect labeling on a controlled substance creates potential for medication errors.
Plain-English summary
Clonazepam 2 mg orally disintegrating tablets (60 tablets per carton) manufactured by Endo USA and distributed by PAR Pharmaceutical have been recalled due to labeling errors. Approximately 9,816 cartons with lot numbers 550176501 and 550176601 (expiring 02/28/2027) were distributed nationwide.
Some cartons contain incorrect labeling on the declared strength. However, the blister strips (the actual tablets) inside each affected carton contain the correct strength formulation.
Patients nationwide who received medications from the affected lots should check their carton labeling against their prescription to ensure accuracy. If the carton labeling does not match the prescribed strength, patients should contact their pharmacy or healthcare provider before taking the medication.
The recalled product
- Product
- CLONAZEPAM (CLONAZEPAM)
- Brand
- CLONAZEPAM
- Manufacturer
- Endo USA, Inc.
- Affected units
- 9,816
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # 550176501
- 550176601
- Exp 02/28/2027.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Endo USA, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same brand · CLONAZEPAM
- SevereClonazepam Tablets Recalled Due to Incorrect Carton Labeling
FDA (Drugs) · 2025-01-15
- CriticalClonazepam Orally Disintegrating Tablets Carton Mislabeled on Declared Strength
FDA (Drugs) · 2025-01-15
- SevereClonazepam Tablets Recalled Due to Carton Labeling Error
FDA (Drugs) · 2025-01-15
- SevereClonazepam Tablets Recalled Due to Carton Labeling Error
FDA (Drugs) · 2024-08-07
Same manufacturer · Endo USA, Inc.
See all →- ModerateBuprenorphine Hydrochloride Injection Recall Due to Particulate Matter
FDA (Drugs) · 2026-05-20
- ModerateEverolimus 2.5 mg tablets recalled after an out of specification impurity result
FDA (Drugs) · 2025-11-05
- ModerateEverolimus 7.5 mg tablets recalled after an out of specification impurity result
FDA (Drugs) · 2025-11-05
- ModerateEverolimus tablets recalled after an out of specification impurity result
FDA (Drugs) · 2025-11-05
- ModerateEverolimus 10 mg tablets recalled after an out of specification impurity result
FDA (Drugs) · 2025-11-05
Same hazard · mis labeling
See all →- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White Herbal Supplement Recalled for Undeclared Walnut Allergen
FDA (Food) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- HighHalyard DAVINCI TRUCUSTOM Foley Catheter Kits Recalled for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02